SCHEMBL27623136

SCHEMBL27623136

O=S(=O)(O)OC1CCCOC1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
GRIN1 Q05586 1/20 0.30
GRIN2B Q13224 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27623135 0.83 CA1 (0.35) CA1CA2
SCHEMBL28756731 0.80 CA1 (0.33) CA1CA2
SCHEMBL707215 0.80 CA1 (0.33) CA1CA2
SCHEMBL31292491 0.80 CA2 (0.57) CA1CA2
SCHEMBL16782376 0.76 CA1 (0.31) CA1CA2
SCHEMBL3130594 0.75 CA2 (0.54) CA1CA2GRIN1GRIN2B
SCHEMBL5155129 0.73 CA1 (0.58) CA1CA2GRIN1GRIN2B
SCHEMBL11575485 0.73 CA1 (0.58) CA1CA2GRIN1GRIN2B
SCHEMBL1889311 0.72 GRIN1 (0.40) CA1CA2GRIN1GRIN2B
Ammonia Solution, Strong SCHEMBL27744923 0.72 CA1 (0.56) CA1CA2GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1681518-A Combination therapy for hepatitis B virus infection using L-FMAU GILEAD SCIENCES INC (US) 2005-10-12 CN disclosed